JP2023513847A5 - - Google Patents

Info

Publication number
JP2023513847A5
JP2023513847A5 JP2022549737A JP2022549737A JP2023513847A5 JP 2023513847 A5 JP2023513847 A5 JP 2023513847A5 JP 2022549737 A JP2022549737 A JP 2022549737A JP 2022549737 A JP2022549737 A JP 2022549737A JP 2023513847 A5 JP2023513847 A5 JP 2023513847A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
point
score
reduction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023513847A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/054066 external-priority patent/WO2021165420A1/en
Publication of JP2023513847A publication Critical patent/JP2023513847A/ja
Publication of JP2023513847A5 publication Critical patent/JP2023513847A5/ja
Pending legal-status Critical Current

Links

JP2022549737A 2020-02-19 2021-02-18 慢性移植片対宿主病の治療方法 Pending JP2023513847A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2020900472 2020-02-19
AU2020900472A AU2020900472A0 (en) 2020-02-19 Method for treating chronic graft versus host disease
PCT/EP2021/054066 WO2021165420A1 (en) 2020-02-19 2021-02-18 Method for treating chronic graft versus host disease

Publications (2)

Publication Number Publication Date
JP2023513847A JP2023513847A (ja) 2023-04-03
JP2023513847A5 true JP2023513847A5 (enExample) 2024-02-29

Family

ID=74701467

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549737A Pending JP2023513847A (ja) 2020-02-19 2021-02-18 慢性移植片対宿主病の治療方法

Country Status (9)

Country Link
US (1) US20230097931A1 (enExample)
EP (1) EP4106776A1 (enExample)
JP (1) JP2023513847A (enExample)
KR (1) KR20220143092A (enExample)
CN (1) CN115361960A (enExample)
AU (1) AU2021222342A1 (enExample)
BR (1) BR112022016448A2 (enExample)
CA (1) CA3168330A1 (enExample)
WO (1) WO2021165420A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3287520A1 (en) 2006-01-13 2018-02-28 Mesoblast International Sàrl Mesenchymal stem cells expressing tnf-alpha receptors
EP4663241A3 (en) 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
AU2018372631B2 (en) 2017-11-22 2025-06-05 Mesoblast International Sarl Cellular compositions and methods of treatment I
AU2024218133A1 (en) * 2023-02-08 2025-09-18 Mesoblast International Sarl Potency assay and manufacturing method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US6251295B1 (en) 1998-01-08 2001-06-26 Nexell Therapeutics Inc. Method for recirculation washing of blood cells
KR20080105555A (ko) * 2007-05-31 2008-12-04 인하대학교 산학협력단 중간엽 골수세포를 이용한 이식편대숙주질환 치료제 및치료방법
EP1795588A1 (en) * 2005-12-07 2007-06-13 Cellerix, S.L. Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease
WO2010025506A1 (en) * 2008-09-03 2010-03-11 Angioblast Systems, Inc. Expansion of haemopoietic precursors
EP4663241A3 (en) * 2010-10-08 2026-03-25 Mesoblast International Sàrl Enhanced msc preparations
MX2016005824A (es) * 2013-11-04 2016-11-18 Isopogen Pty Ltd Metodo de cultivo celular.
CN110753751A (zh) * 2017-05-04 2020-02-04 迈索布拉斯特国际有限公司 具有增强的免疫抑制的间充质谱系前体或干细胞

Similar Documents

Publication Publication Date Title
RU2647467C2 (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
KR101830290B1 (ko) 지방 유래 줄기세포로부터 추출된 엑소좀을 유효성분으로 포함하는 폐 섬유증 예방 또는 치료용 조성물
US20120171161A1 (en) Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
Fujio et al. Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors
US20250213611A1 (en) Compositions and methods for treatment of amyotrophic lateral sclerosis (als) and other neurodegenerative diseases, and associated methods for preparing said compositions
Novotny et al. Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB
Lambertsen et al. Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice
Galipeau Mesenchymal stromal cells for graft-versus-host disease: a trilogy
KR102088767B1 (ko) 혼합물 4f를 이용한 줄기세포 생물학적 활성 증가용 조성물
WO2014082514A1 (zh) 一种启动哺乳动物干细胞的方法及二氧化氯在制备用于启动哺乳动物干细胞的药物的应用
US20210230537A1 (en) Angiogenesis using stimulated placental stem cells
RU2368384C2 (ru) Биотрансплантат, способ лечения хронических заболеваний печени и способ лечения цирроза печени и портальной гипертензии
JP2023512843A5 (enExample)
JP7045670B2 (ja) 多能性幹細胞による虚血再灌流肺障害の軽減及び治療
US20230097931A1 (en) Method for treating chronic graft versus host disease
JP2023517035A5 (enExample)
JP2023517636A (ja) 炎症性腸疾患を治療するための方法ｉ
McCully et al. Therapeutic mitochondrial transplantation
JP5602364B2 (ja) 幹細胞及び／又は前駆細胞の賦活剤
US12569460B2 (en) Application of thyroid hormones and thyroid hormone analogues to preparation of drugs for treating sickle-cell disease
CN117085039A (zh) Cd177抑炎型中性粒细胞对缺血性脑卒中治疗的应用
WO2023098088A1 (zh) 外泌体在胸主动脉夹层/动脉瘤中的作用
US20210338713A1 (en) Reduction of Pulmonary Inflammation Using Therapeutic Gas Mixtures
Yin et al. Inducing macrophage polarization to M2 anti-inflammatory type reduces oxidative damage in diabetic retinopathy mice
Yuyan et al. Research progress of mesenchymal stem cells for graft-versus-host disease